Glucosamine Market Analysis & Forecast: 2026-2033

Glucosamine Market Size and Share Analysis - Growth Trends and Forecast (2026 - 2033)

The global glucosamine market size is estimated to reach USD 1,040 Mn in 2026 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% during the forecast period (2026-2033), surpassing USD 1,480 Mn by 2033. This growth can be attributed to rising prevalence of osteoarthritis and other joint-related disorders, increasing geriatric population, and growing consumer awareness regarding preventive healthcare and joint health supplements. The global population aged 60 and above is expected to grow from 1.1 billion in 2023 to 1.4 billion by 2030.

Key Takeaways from the Glucosamine Market Report

• Capsules are expected to account for the largest market share of around 38% in 2026, owing to rising consumer preference for convenient, pre-measured dosing and ease of consumption.
• Retail pharmacies segment is likely to account for a market share of over 40% in 2026 due to trust and accessibility. On the other hand, online pharmacies segment is anticipated to witness the fastest growth during the forecast period.
• North America is projected to lead the global glucosamine industry with a share of 39% in 2026 due to high consumer awareness of joint health supplements, strong presence of key nutraceutical manufacturers, and increasing prevalence of osteoarthritis and other musculoskeletal disorders.
• Asia Pacific, capturing a share of over 30% in 2026, is poised to emerge as the fastest-growing market for glucosamine during the forecast period, thanks to high elderly population, strong supplement culture, and rising health awareness across nations like China, Japan, and India.

Glucosamine Market Overview

The global glucosamine market is expected to register steady growth over the forecast period. This is due to increasing prevalence of osteoarthritis, rheumatoid arthritis, and other joint-related disorders. Similarly, growing aging global population and expanding demand for glucosamine from nutraceutical and sports nutrition industries are supporting market expansion.

Glucosamine is an amino sugar naturally present in the human body and is commonly used as a dietary supplement. Commercially, it is mainly produced through the hydrolysis of chitin from shellfish exoskeletons or via microbial fermentation methods. It is available in forms such as glucosamine sulfate, glucosamine hydrochloride, and N-acetylglucosamine.

Glucosamine is often used alone or in combination with chondroitin for the symptomatic management of osteoarthritis, particularly of the knee. Rising adoption of this dietary supplement for health conditions like joint pain and arthritis is boosting sales growth. The use of glucosamine in animal feed and pet health products is also increasing significantly, leading to higher market demand.

Increasing demand for natural and alternative therapies is expected to boost the glucosamine market during the forecast period. Modern consumers prefer natural remedies over synthetic drugs for joint pain relief. Glucosamine is perceived as a safe, naturally occurring compound, boosting demand.

Segmental Insights 

To learn more about this report, Request Free Sample

Which Product Type Leads the Glucosamine Market?

Glucosamine Capsules Lead the Market with Nearly a Two-Fifths Share in 2026

According to Coherent Market Insights’ latest glucosamine market analysis, capsules segment is projected to hold a prominent share of 38% in 2026. This dominance is due to their ease of consumption, precise dosage control, and strong consumer preference for convenient oral supplement formats.

Glucosamine capsules are widely available across pharmacies, health stores, and e-commerce platforms, making them easily accessible to a broad consumer base. In addition, manufacturers favor capsules because they offer better stability for active ingredients like glucosamine, helping preserve potency and extending shelf life compared to some alternative formulations.

Which Distribution Channel Dominates the Glucosamine Industry? 

To learn more about this report, Request Free Sample

Retail Pharmacies Lead Global Glucosamine Sales in 2026

By distribution channel, retail pharmacies segment is expected to dominate the glucosamine industry with a share of 40% in 2026. This is attributable to their strong accessibility, consumer trust, and widespread presence across both urban and semi-urban regions. Retail pharmacies offer easy over-the-counter availability of glucosamine supplements without the need for prescriptions. This makes them the preferred purchasing channel for aging populations and individuals managing joint health conditions.

Glucosamine Market Growth Drivers

Rising Prevalence of Joint Disorders

There is a spike in the cases of osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. For instance, according to the World Health Organization (WHO), about 1.71 billion people worldwide live with musculoskeletal conditions, including back pain, osteoarthritis, rheumatoid arthritis, neck pain, and fractures. This, in turn, is expected to drive demand for glucosamine because it is widely used as a dietary supplement to support joint health, reduce inflammation, and alleviate pain associated with cartilage degeneration.

Growing Geriatric Population

According to the World Health Organization, the global population aged 60 years and above is projected to reach approximately 2.1 billion by 2050. This rapid demographic shift is expected to drive demand for joint health supplements, including glucosamine because older adults are more prone to age-related joint disorders. Thus, the expanding elderly population is anticipated to foster growth of the glucosamine market during the forecast period.

Glucosamine Market Opportunities

Expansion of Dietary Supplements Industry

Glucosamine is widely used in nutraceuticals and dietary supplements. Its availability in multiple formats, such as capsules, powders, and tablets, enhances accessibility as well as supports wider consumer adoption. Therefore, growing demand for dietary supplements is expected to create lucrative growth opportunities for the glucosamine market during the forecast period.

Glucosamine Market Trends

Shift Towards Vegan and Plant-based Glucosamine

Rising vegan population and increasing concerns related to shellfish allergies are driving the demand for fermentation-based and plant-derived glucosamine. Glucosamine is usually made from shellfish, but it is now also being produced through microbial fermentation  to meet the needs of vegan consumers. Many leading manufacturers are developing vegan glucosamine products to woo vegans as well as improve their market position.

Growing Interest in Functional Food Fortification

Rising adoption of glucosamine in functional foods and beverages is a key growth-shaping trend. Some manufacturers are incorporating glucosamine in fortified products like nutrition bars and beverages. This emerging trend, supported by increasing consumer interest in functional nutrition, is expected to create new growth avenues for glucosamine during the forthcoming period.

Current Events and Their Impact on the Glucosamine Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Regional Insights 

To learn more about this report, Request Free Sample

High Arthritis Burden Driving Glucosamine Demand in North America

North America is expected to dominate the global glucosamine market with a 39% share in 2026. This can be attributed to high prevalence of arthritis and a rapidly aging population, which increases demand for joint health and preventive nutrition supplements. Growing awareness of osteoarthritis management through dietary supplements is also boosting North America glucosamine market.

According to the U.S. Centers for Disease Control and Prevention (CDC), about 1 in 4 adults (around 54 million people) in the United States have arthritis. This large patient base boosts demand for glucosamine-based products used for joint pain relief and mobility support.

Aging Population and Rising Supplement Adoption Boosting Sales in Asia Pacific

Asia Pacific is forecast to emerge as a hotbed for manufacturers of glucosamine during the forecast period, capturing a global market share of 30% in 2026. This is mainly due to a rapidly aging population, increasing awareness of bone and joint health, and growing adoption of dietary supplements. Rising disposable income and improved access to nutraceuticals are also fostering growth of Asia Pacific glucosamine market.

According to the United Nations, Asia is home to the largest share of the global elderly population, with countries like Japan already having over 29% of its population aged 65 and above, making it one of the most aged societies globally. This demographic shift is significantly increasing cases of osteoarthritis and joint degeneration, thereby supporting demand for glucosamine-based supplements.

Glucosamine Market Outlook – Country-wise

U.S. Glucosamine Market Trends

The United States is likely to remain one of the leading markets for glucosamine during the forecast period. This is mostly due to high prevalence of osteoarthritis and a growing aging population seeking joint health supplements. According to the U.S. Census Bureau, the number of adults aged 65 and above is projected to reach nearly 80 million by 2040, significantly increasing demand for mobility-support and cartilage health products like glucosamine.

In addition, strong consumer preference for preventive healthcare and widespread availability of dietary supplements through pharmacies, online retail, and wellness stores continue to support market expansion. The rising adoption of combination supplements (glucosamine with chondroitin and MSM) further strengthens product demand across the country.

China Glucosamine Market Forecast

China’s glucosamine market is poised to exhibit strong growth during the assessment period. This can be attributed to rising geriatric population and increasing awareness of bone and joint health among middle-aged and elderly consumers. According to China’s National Bureau of Statistics, the population aged 60 and above continues to expand, creating a strong base for nutraceutical demand. In addition, expanding e-commerce penetration and improved availability of imported as well as domestic supplement brands are fostering glucosamine market growth in the nation.

Who are the Major Companies in the Glucosamine Market?

Some of the major players in Glucosamine Market are Bio-gen Extracts Private Limited, Panvo Organics Pvt Ltd, Pharma Base S.A., CAPTEK Softgel International Inc., TSI Health Sciences, Inc., Cargill, CellMark Chemicals, Andra Medi Pharma Pvt. Ltd, Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd. (PXPC), JIAXING HENGJIE BIOPHARMACEUTICAL CO.,LTD. , Wellable Marine Biotech Holding Limited, Zhejiang Shinfuda Marine Biotechnology Corp, Spectrum Chemical Manufacturing Corporation, Atlina Life Sciences, Schiff Nutrition International, Inc. and Golden-Shell Pharmaceutical Co. Ltd.

Key Strategies Adopted by Industry Players

Leading glucosamine manufacturers are adopting various strategies to strengthen their position as well as expand consumer reach. These include new product launches, partnerships, mergers, acquisitions, and agreements. For example,

• In April 2026, Fusen Pharmaceutical announced that its Glucosamine Sulfate Capsules were approved by China’s National Medical Products Administration (NMPA). The medicine is approved for the treatment of primary and secondary osteoarthritis.
• In 2025, Rundu Co., Ltd. received approval from China’s National Medical Products Administration (NMPA) for its glucosamine sulfate product used to treat osteoarthritis. This approval helped the company expand its presence in the joint health treatment market.

Market Report Scope 

Analyst Opinion (Expert Opinion)

• Demand is structurally anchored in osteoarthritis prevalence, not consumer trends. Osteoarthritis affects over 528 million people globally (7% of the population). This creates a large, aging patient base requiring long-term symptom management, directly sustaining demand for glucosamine-based therapies and supplements.
• Clinical outcomes remain mixed, limiting full medical endorsement and pricing power. Meta-analyses show glucosamine can deliver 22% pain improvement and 11% functional improvement in osteoarthritis patients, but results are inconsistent across formulations and studies. This variability constrains its transition from supplement to universally recommended pharmaceutical therapy, keeping the market fragmented.
• Chronic use supports steady repeat demand, but also increases safety concerns over time. Large studies with over 685,000 patients show many osteoarthritis patients use it long-term. However, some data suggest a possible higher cardiovascular risk (HR ~1.10–1.68 based on use), which may lead to more medical and regulatory attention and affect future use as well as perception.

Market Segmentation

• By Product Type Insights ( Revenue, US$ Mn, 2021 - 2033)
  • Powder
  • Tablets
  • Capsules
  • Liquid
• By Application Insights ( Revenue, US$ Mn, 2021 - 2033)
  • Rheumatoid Arthritis
  • Asthma
  • Inflammatory Bowel Disease
  • Others
• By Distribution Channel Insights ( Revenue, US$ Mn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region Insights ( Revenue, US$ Mn, 2021 - 2033)
  • North America 
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa

Sources

Primary Research Interviews

• Manufacturers of glucosamine and dietary supplements
• Raw material suppliers
• Distributors and wholesalers
• Healthcare professionals (orthopedic specialists, rheumatologists, and pharmacists)
• Regulatory experts
• Industry executives and product managers

Databases

• PubMed
• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• World Health Organization (WHO)
• National Center for Biotechnology Information (NCBI)
• ClinicalTrials.gov

Magazines

• Nutraceuticals World
• Natural Products Insider
• Food Technology Magazine
• Health & Nutrition Magazine

Journals

• Journal of Dietary Supplements
• Osteoarthritis and Cartilage
• The American Journal of Clinical Nutrition
• Journal of Nutrition
• BMC Musculoskeletal Disorders

Newspapers

• The New York Times
• The Guardian
• The Wall Street Journal
• The Economic Times

Associations

• Council for Responsible Nutrition (CRN)
• International Alliance of Dietary/Food Supplement Associations (IADSA)
• American College of Rheumatology (ACR)
• Arthritis Foundation
• International Osteoporosis Foundation (IOF)

Public Domain sources

• Annual reports and investor presentations of supplement manufacturers
• Government health statistics and regulatory publications
• Import-export data from customs authorities
• Clinical study reports
• White papers
• Company websites and product catalogs

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years